Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Günther Bernhardt

Showing results (1-10 of 103) with videos related to

Pageof 11
Sort By:
Archiv Der Pharmazie|December 7, 2020
Derivatives of nitrogen mustard anticancer agents with improved cytotoxicityFrauke Antoni, Günther Bernhardt
ACS Medicinal Chemistry Letters|June 22, 2019
Modifications at Arg and Ile Give Neurotensin(8-13) Derivatives with High Stability and Retained NTS<sub>1</sub> Receptor AffinityLisa Schindler, Günther Bernhardt, Max Keller
Methods in Molecular Biology (Clifton, N.J.)|May 29, 2021
Quantitative Determination and Imaging of Gα<sub>q</sub> Signaling in Live Cells via Split-Luciferase ComplementationTimo Littmann, Takeaki Ozawa, Günther Bernhardt
Chemmedchem|July 7, 2011
[³H]UR-MK136: a highly potent and selective radioligand for neuropeptide Y Y₁ receptorsMax Keller, Günther Bernhardt, Armin Buschauer
Analytical Biochemistry|March 12, 2019
Split luciferase-based assay for simultaneous analyses of the ligand concentration- and time-dependent recruitment of β-arrestin2Timo Littmann, Armin Buschauer, Günther Bernhardt
Journal of Cancer Research and Clinical Oncology|June 1, 2006
Platelet-derived growth factor receptor independent proliferation of human glioblastoma cells: selective tyrosine kinase inhibitors lack antiproliferative activityDietmar Gross, Günther Bernhardt, Armin Buschauer
European Journal of Medicinal Chemistry|November 17, 2020
Water-soluble inhibitors of ABCG2 (BCRP) - A fragment-based and computational approachFrauke Antoni, David Wifling, Günther Bernhardt
Archiv Der Pharmazie|April 18, 2015
Toward Labeled Argininamide-Type NPY Y1 Receptor Antagonists: Identification of a Favorable Propionylation Site in BIBO3304Max Keller, Lisa Schindler, Günther Bernhardt, et al.
The Journal of Organic Chemistry|November 25, 2003
Tetrahydroxy 10-membered cyclic enediynesMichael Klein, Manfred Zabel, Günther Bernhardt, et al.
Chemmedchem|August 13, 2009
Bivalent argininamide-type neuropeptide y y(1) antagonists do not support the hypothesis of receptor dimerisationMax Keller, Shangjun Teng, Günther Bernhardt, et al.
Pageof 11

Showing results (1-10 of 103) with videos related to

Sort By:
Pageof 11
Archiv Der Pharmazie|December 7, 2020
Derivatives of nitrogen mustard anticancer agents with improved cytotoxicityFrauke Antoni, Günther Bernhardt
ACS Medicinal Chemistry Letters|June 22, 2019
Modifications at Arg and Ile Give Neurotensin(8-13) Derivatives with High Stability and Retained NTS<sub>1</sub> Receptor AffinityLisa Schindler, Günther Bernhardt, Max Keller
Methods in Molecular Biology (Clifton, N.J.)|May 29, 2021
Quantitative Determination and Imaging of Gα<sub>q</sub> Signaling in Live Cells via Split-Luciferase ComplementationTimo Littmann, Takeaki Ozawa, Günther Bernhardt
Chemmedchem|July 7, 2011
[³H]UR-MK136: a highly potent and selective radioligand for neuropeptide Y Y₁ receptorsMax Keller, Günther Bernhardt, Armin Buschauer
Analytical Biochemistry|March 12, 2019
Split luciferase-based assay for simultaneous analyses of the ligand concentration- and time-dependent recruitment of β-arrestin2Timo Littmann, Armin Buschauer, Günther Bernhardt
Journal of Cancer Research and Clinical Oncology|June 1, 2006
Platelet-derived growth factor receptor independent proliferation of human glioblastoma cells: selective tyrosine kinase inhibitors lack antiproliferative activityDietmar Gross, Günther Bernhardt, Armin Buschauer
European Journal of Medicinal Chemistry|November 17, 2020
Water-soluble inhibitors of ABCG2 (BCRP) - A fragment-based and computational approachFrauke Antoni, David Wifling, Günther Bernhardt
Archiv Der Pharmazie|April 18, 2015
Toward Labeled Argininamide-Type NPY Y1 Receptor Antagonists: Identification of a Favorable Propionylation Site in BIBO3304Max Keller, Lisa Schindler, Günther Bernhardt, et al.
The Journal of Organic Chemistry|November 25, 2003
Tetrahydroxy 10-membered cyclic enediynesMichael Klein, Manfred Zabel, Günther Bernhardt, et al.
Chemmedchem|August 13, 2009
Bivalent argininamide-type neuropeptide y y(1) antagonists do not support the hypothesis of receptor dimerisationMax Keller, Shangjun Teng, Günther Bernhardt, et al.
Pageof 11